Abstract
Strategies for the prevention of superficial bladder cancer recurrence after TUR-Bt are discussed in relation to each cause of the recurrence. Implantation of tumor cells, coexisting dysplasia and CIS, and residual microlesion are theoretically able to be eliminated by intravesical chemotherapy or BCG instillation adjacent to the time of TUR-Bt.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
